Deep Insights from the Experts
Growth Advisory
Technology | IP Research & Intelligence
Investment Research & Analytics
Valuation & Financial Advisory
For over a century, water treatment has relied on chemical inputs such as metal salts, chlorine, and synthetic polymers to deliver safe and cost-effective outcomes, though often leaving behind sludge, harmful byproducts, and gaps in ...read more
published on Jul 02, 2026
South Korea’s battery energy storage system (BESS) industry is moving through a structural reset. What began as a natural extension of the country’s electric vehicle (EV) battery strength is now becoming a core pil ...read more
published on Jul 02, 2026
For years, the most contested frontier in corporate climate accountability has been Scope 3 the emissions that occur not within a company's own operations or its direct energy supply, but across its entire value chain: upstream ...read more
published on Jul 01, 2026
There is a particular kind of regulatory development that changes the climate conversation without announcing itself as a climate announcement. It does not come with a net zero target or a sustainability strategy. It arrives ...read more
published on Jun 30, 2026
Type 1 diabetes, once considered a lifelong affliction requiring constant management, has seen remarkable advancements in recent years, particularly in the field of alternative therapies. The traditional management of type 1 diabetes involves daily insulin injections or ...read more
published on Jul 10, 2024
Net zero energy buildings (NZEBs) are transforming the landscape of sustainable construction through global regulatory support, major technological advancements, and innovative design practices. The surge in patent filings reflects intensified research and development efforts by ...read more
published on Jun 27, 2024
Type 1 diabetes results from intricate interactions between genetic predisposition and environmental triggers. Existing treatments often fall short of providing sustained relief, prompting the search for alternative solutions. Gene therapy offers such avenues by either reprogramming ...read more
published on Apr 19, 2024
Type 1 diabetes (T1D) is a complex autoimmune disease with a multifactorial etiology. Genetic predisposition, environmental triggers, and immune dysregulation contribute to the development of this chronic condition. Diagnoses involves a combination of clinical evaluation, ...read more
published on Apr 12, 2024
Immersive technology encompassing AR, VR, and MR is revolutionizing how we interact with digital content, enabling lifelike, engaging experiences across healthcare, education, retail, and defense. Companies are leveraging it to boost productivity, cut costs, and ...read more
published on Jul 31, 2025
“Investing with Faith: The Rise and Reach of Halal Investments” explores how faith-driven finance is transforming global markets. It outlines the principles of Halal investing, rooted in Shariah law—prohibiting interest, gambling, and ...read more
published on Jun 25, 2025
Despite multiple interventions, Vodafone Idea remains trapped in a cycle of high debt, regulatory overhang, and underinvestment. With dwindling subscriber share and a growing capex gap versus rivals Jio and Airtel, Vi’s future as a ...read more
published on Jun 23, 2025
As the U.S. considers imposing a 25% tariff on iPhones manufactured abroad, Apple is under pressure to shift production from India to the U.S. However, such a transition is economically unviable. Producing an iPhone ...read more
published on Jun 13, 2025
Complex securities are financial instruments whose value cannot be determined by reference to a quoted market price. Understanding what they are, why they are difficult to value, and when independent valuation is required is the ...read more
published on Jun 12, 2026
Whether the acquisition is governed by ASC 805 or IFRS 3 determines what needs to be identified, how goodwill is calculated, and how earnouts and minority interests are measured at the acquisition date. Why the standard you ...read more
published on Jun 02, 2026
When you acquire a business, the purchase price you paid must be allocated across the identifiable assets and liabilities of the acquired company. This process (purchase price allocation) is not optional, and getting it right ...read more
published on May 29, 2026
If you are granting stock options to employees, you need a 409A valuation. This guide explains what it is, why it exists, what happens if you skip it, and what to look for when commissioning ...read more
published on May 19, 2026
© , Aranca. All rights reserved.
